tiprankstipranks
Trending News
More News >
Larimar Therapeutics price target lowered to $10 from $13 at Baird
PremiumThe FlyLarimar Therapeutics price target lowered to $10 from $13 at Baird
1M ago
Larimar Therapeutics Reports 2024 Financial Results and Development Progress
Premium
Company Announcements
Larimar Therapeutics Reports 2024 Financial Results and Development Progress
1M ago
Promising Prospects for Larimar Therapeutics: Buy Rating Affirmed Amid FDA Support and Strong Financial Position
Premium
Ratings
Promising Prospects for Larimar Therapeutics: Buy Rating Affirmed Amid FDA Support and Strong Financial Position
1M ago
Apple downgraded, Rivian initiated: Wall Street’s top analyst calls
PremiumThe FlyApple downgraded, Rivian initiated: Wall Street’s top analyst calls
3M ago
Truist sees ‘significant upside’ for Larimar Therapeutics, starts with a Buy
Premium
The Fly
Truist sees ‘significant upside’ for Larimar Therapeutics, starts with a Buy
3M ago
Larimar Therapeutics initiated with a Buy at Truist
Premium
The Fly
Larimar Therapeutics initiated with a Buy at Truist
3M ago
Larimar Therapeutics trading halted, volatility trading pause
PremiumThe FlyLarimar Therapeutics trading halted, volatility trading pause
4M ago
Larimar Therapeutics announces initial data from OLE study of nomlabofusp
Premium
The Fly
Larimar Therapeutics announces initial data from OLE study of nomlabofusp
4M ago
Larimar Therapeutics presents Phase 1 and 2 dose studies of nomlabofusp
Premium
The Fly
Larimar Therapeutics presents Phase 1 and 2 dose studies of nomlabofusp
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100